/
Teleflex Incorporated is referred to herein as we, us, our, Teleflex and the Company. THE COMPANY Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs.
12.84% operating margin is respectable but not wide. ROIC at 3.39%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 17.2%, still solid. Margins contracted 2.1pp, which offsets some of the top-line progress.
Free cash flow declined 99% versus the prior year, cash generation momentum has weakened. Net debt of $2.37B represents 1637.4x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
$2.13B
▲ +17.2% YoY
Net Income (TTM)
-$1.01B
▼ -1399.8% YoY
Op. Margin
9.41%
▼ -2.1pp YoY
ROIC
2.58%
▲ +0.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$26M
▼ -99.3% YoY
Op. Cash Flow (TTM)
$116M
▼ -68.0% YoY
Net Debt
$2.47B
Cash & Equiv.
$309M
5Y CAGR: -4.7%
5Y CAGR: -66.6%
Continue Research